Cutler Group LP Igm Biosciences, Inc. Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$6.66 - $10.64 $2,664 - $4,256	400 New	400 $3,000
Q4 2022 Feb 07, 2023	SELL	$15.45 - $26.02 $154 - $260	-10 Reduced 9.09%	100 $1,000
Q3 2022 Oct 25, 2022	BUY	$15.42 - $27.01 $1,696 - $2,971	110 New	110 $2,000
Q1 2022 Apr 14, 2022	BUY	$13.42 - $29.73 $9,394 - $20,811	700 New	700 $18,000

20.7M

68K

52.2K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $189M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.